LUCD · Company research

Lucid Diagnostics Inc. (LUCD): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

14records availableHealthcare

Stock News & Events data

Database-backed records only

14 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
A new billing code was approved for a tool that collects esophageal cells. Medicare payment remains pending. - Stock TitanA new billing code was approved for a tool that collects esophageal cells. Medicare payment remains pending. Stock TitanView source ↗Stock TitanSep 22, 2026neutral00.6
LUCD Technical Analysis & Stock Price Forecast - Intellectia AILUCD Technical Analysis & Stock Price Forecast Intellectia AIView source ↗Intellectia AIAug 22, 2026neutral00.6
Lucid Diagnostics Could Be 'High In The Queue' For Medicare Coverage Decision, Analyst Says - BenzingaLucid Diagnostics Could Be 'High In The Queue' For Medicare Coverage Decision, Analyst Says BenzingaView source ↗BenzingaAug 18, 2026neutral00.6
Lucid Diagnostics Inc (NASDAQ: LUCD) Share Price, LUCD Stock News, LUCD Share Price & Updates - KalkineLucid Diagnostics Inc (NASDAQ: LUCD) Share Price, LUCD Stock News, LUCD Share Price & Updates KalkineView source ↗KalkineAug 14, 2026neutral00.6
Lucid Diagnostics (LUCD) Slips 1.98% to $0.96 as Shares Hover Above Key Support - Runaway Gap - dars.gov.etLucid Diagnostics (LUCD) Slips 1.98% to $0.96 as Shares Hover Above Key Support - Runaway Gap dars.gov.etView source ↗dars.gov.etAug 13, 2026neutral00.6
Lucid Diagnostics (LUCD) Stock Slips As Lofty P S Meets Heavy Losses - Simply Wall StreetLucid Diagnostics (LUCD) Stock Slips As Lofty P S Meets Heavy Losses Simply Wall StreetView source ↗Simply Wall StreetAug 13, 2026neutral00.6
Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo FinanceLucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Lags Revenue Estimates Yahoo FinanceView source ↗Yahoo FinanceAug 13, 2026neutral00.6
Lucid's EsoGuard Is the Only Esophageal Precancer Test Meeting Coverage Criteria - Stock TitanLucid's EsoGuard Is the Only Esophageal Precancer Test Meeting Coverage Criteria Stock TitanView source ↗Stock TitanAug 5, 2026neutral00.6
$LUCD stock is down 12% today. Here's what we see in our data. - Quiver Quantitative$LUCD stock is down 12% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeJul 16, 2026neutral00.6
Lucid Diagnostics: Positioned For A Medicare-Driven Inflection (NASDAQ:LUCD) - Seeking AlphaLucid Diagnostics: Positioned For A Medicare-Driven Inflection (NASDAQ:LUCD) Seeking AlphaView source ↗Seeking AlphaJul 3, 2026neutral00.6
LUCD Forecast — Price Target — Prediction for 2027 - TradingViewLUCD Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 25, 2026neutral00.6
Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results - Yahoo FinanceWhy Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results Yahoo FinanceView source ↗Yahoo FinanceJun 2, 2026neutral00.6
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results - PR NewswireLucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results PR NewswireView source ↗PR NewswireMay 14, 2026neutral00.6
Lucid Diagnostics Inc. (LUCD) Stock Rises on Q4 2025 Earnings - Quiver QuantitativeLucid Diagnostics Inc. (LUCD) Stock Rises on Q4 2025 Earnings Quiver QuantitativeView source ↗Quiver QuantitativeMar 25, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.